Crescent Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2016
Total Assets: $42.4M
Liabilities Breakdown FY2016
Total Liabilities: $7.1M
Asset Breakdown
Total Assets: $42.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $40.0M | 94.5% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.1M | 2.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.3M | 3.0% |
Liabilities Breakdown
Total Liabilities: $7.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.6M | 22.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $5.5M | 77.9% |